Juan Ibla

Dr. Juan Ibla

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JKJoseph Khoury
Joseph Khoury
JIJuan Ibla
Juan Ibla
ANAndrew S. Neish
Andrew S. Neish
SCSean P. Colgan
Sean P. Colgan
A major adaptive pathway for hypoxia is hypoxic preconditioning (HPC), a form of endogenous protection that renders cells tolerant to severe challenges of hypoxia. We sought to define the antiinflammatory properties of HPC. cDNA microarray analysis of lung tissue from mice subjected to hypoxia or HPC identified a cluster of NF-κB–regulated genes whose expression is attenuated by HPC. Studies using an NF-κB luciferase reporter assay confirmed a significant suppression of NF-κB activation during HPC. HPC-elicited activity was conferrable, as a soluble supernatant from HPC-treated cells, and the active fraction was purified and identified as adenosine (Ado). Guided by recent studies demonstrating bacterial inhibition of NF-κB through cullin-1 (Cul-1) deneddylation, we found a dose-dependent deneddylation of Cul-1 by Ado receptor stimulation predominantly mediated by the Ado A2B receptor subtype. Further, siRNA-mediated repression of CSN5, a subunit of the COP9 signalosome responsible for deneddylation of Cul-1, partially reversed HPC-mediated inhibition of NF-κB. Cul-1 deneddylation was evident in a murine model of HPC and lost in animals lacking extracellular Ado (Cd73–/– mice). Taken together, these results demonstrate that HPC induces extracellular accumulation of Ado and suppresses NF-κB activity through deneddylation of Cul-1. These results define a molecular regulatory pathway by which Ado provides potent antiinflammatory properties.

28 March 2013 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
HDHong-Wei Dong
Hong-Wei Dong
SZShuang Zhang
Shuang Zhang
WSWen-Guang Sun
Wen-Guang Sun
QLQian Liu
Qian Liu
JIJuan Ibla
Juan Ibla
JLJiaren Liu
Jiaren Liu

1 May 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
QLQian Liu
Qian Liu
JLJing Li
Jing Li
JKJoseph Khoury
Joseph Khoury
SCSean P. Colgan
Sean P. Colgan
JIJuan Ibla
Juan Ibla
Small ubiquitin-like modifier 1 (SUMO-1) modification of IκBα has been described to actively participate in NFκB regulation. Following proteosomal degradation of IκBα, an auto-regulatory loop consisting of transcriptional activation of IκBα gene and SUMO-1 modification of newly synthesized IκBα proceeds. The SUMOylated IκBα form is resistant to signal-induced degradation, consequently halting NFκB activation. We describe a mechanistic model by which adenosine (Ado) signaling results in significant accumulation of SUMO-1 modified IκBα with subsequent attenuation of NFκB activation. Using models of hypoxia followed by reoxygenation (H/R), we have documented an H/R cycle-dependent increase in extracellular Ado correlating with increases in the cytoplasmic pool of IκBα/SUMO-1. We demonstrate a dose-dependent increase in IκBα/SUMO in cells treated with the general Ado receptor agonist NECA and abolished by Ado receptor antagonists. Experiments in cells exposed to cycles of H/R followed by hypoxia demonstrated differential patterns of SUMOylation and phosphorylation of IκBα, greatly impacting its proteosomal degradation by the 26 S proteasome. Assays targeting knockdown and overexpression of SUMO-1 demonstrated significant regulation of NFκB activation and NFκB-mediated gene transcription (interleukin-6). These results were confirmed in vivo using wild type and cd73 null mouse lung tissue. In summary, we present an endogenous mechanism by which cells and tissues acquire anti-inflammatory properties by recruiting a nondegradable form of IκBα, a major control point for NFκB activation via Ado signaling.

Verified
Journal Article
Open access
PDF file
RHRyan Hunt
Ryan Hunt
GHGaya Hettiarachchi
Gaya Hettiarachchi
UKUpendra Katneni
Upendra Katneni
NHNancy Hernandez
Nancy Hernandez
DHDavid Holcomb
David Holcomb
CKChava Kimchi-Sarfaty
Chava Kimchi-Sarfaty
Synonymous variants within coding regions may influence protein expression and function. We have previously reported increased protein expression levels ex vivo (~120% in comparison to wild-type) from a synonymous polymorphism variant, c.354G>A [p.P118P], of the ADAMTS13 gene, encoding a plasma protease responsible for von Willebrand Factor (VWF) degradation. In the current study, we investigated the potential mechanism(s) behind the increased protein expression levels from this variant and its effect on ADAMTS13 physico-chemical properties. Cell-free assays showed enhanced translation of the c.354G>A variant and the analysis of codon usage characteristics suggested that introduction of the frequently used codon/codon pair(s) may have been potentially responsible for this effect. Limited proteolysis, however, showed no substantial influence of altered translation on protein conformation. Analysis of post-translational modifications also showed no notable differences but identified three previously unreported glycosylation markers. Despite these similarities, p.P118P variant unexpectedly showed higher specific activity. Structural analysis using modeled interactions indicated that subtle conformational changes arising from altered translation kinetics could affect interactions between an exosite of ADAMTS13 and VWF resulting in altered specific activity. This report highlights how a single synonymous nucleotide variation can impact cellular expression and specific activity in the absence of measurable impact on protein structure.

29 December 2018 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
UKUpendra Katneni
Upendra Katneni
JIJuan Ibla
Juan Ibla
RHRyan Hunt
Ryan Hunt
TSTal Schiller
Tal Schiller
CKChava Kimchi-Sarfaty
Chava Kimchi-Sarfaty

1 December 2017 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
RHR. Hunt
R. Hunt
CHC. M. Hoffman
C. M. Hoffman
SES. Emani
S. Emani
CTC. C. Trenor
C. C. Trenor
SES. M. Emani
S. M. Emani
JIJuan Ibla
Juan Ibla